Aktis Oncology, Inc.AKTSNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$11.90M
↑ 184% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-14.10M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $11.90M | +135.2% |
| 2023 | $-33.77M | -65.3% |
| 2022 | $-20.43M | - |